|
RTTN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.638930E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.937050E-03 |
| Normal-vs-Stage2 |
2.420400E-02 |
| Normal-vs-Stage3 |
6.791000E-04 |
| Normal-vs-Stage4 |
5.8027000000016E-05 |
| Stage1-vs-Stage2 |
5.841200E-01 |
| Stage1-vs-Stage3 |
5.558200E-01 |
| Stage1-vs-Stage4 |
5.549900E-02 |
| Stage2-vs-Stage3 |
3.013000E-01 |
| Stage2-vs-Stage4 |
3.572500E-02 |
| Stage3-vs-Stage4 |
2.341600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.041200E-04 |
| Normal-vs-AfricanAmerican |
1.229440E-01 |
| Normal-vs-Asian |
5.283600E-03 |
| Caucasian-vs-AfricanAmerican |
7.518000E-01 |
| Caucasian-vs-Asian |
4.200600E-01 |
| AfricanAmerican-vs-Asian |
2.979000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.16569999999372E-05 |
| Normal-vs-Female |
1.099750E-01 |
| Male-vs-Female |
4.186200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.424000E-01 |
| Normal-vs-Extreme_Weight |
1.86068999999955E-05 |
| Normal-vs-Obese |
4.624300E-04 |
| Normal-vs-Extreme_Obese |
1.221380E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.436800E-01 |
| Normal_Weight-vs-Obese |
4.958000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.255600E-01 |
| Extreme_Weight-vs-Obese |
4.039200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.515200E-01 |
| Obese-vs-Extreme_Obese |
2.565800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.214400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.231600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.9964000000392E-06 |
| Normal-vs-Age(81-100Yrs) |
6.601900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.806600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.314980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.086400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.649820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.910200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.066800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.035000E-04 |
| Normal-VS-Type2 PRCC |
2.464300E-02 |
| Normal-VS-KIRP CIMP |
3.023800E-03 |
| Normal-VS-Unclassified PRCC |
1.075700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.177800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.757760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.586800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.105200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.949200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.403800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.961900E-03 |
| Normal-vs-N1 |
3.816400E-04 |
| Normal-vs-N2 |
2.816000E-03 |
| N0-vs-N1 |
3.456000E-01 |
| N0-vs-N2 |
3.519000E-03 |
| N1-vs-N2 |
9.692400E-02 |
|
|
